Newsroom
Sorted by: Latest
-
Citibank UK Regulatory Announcement: FRN Variable Rate Fix
LONDON--(BUSINESS WIRE)-- Re: SNB FUNDING LIMITED USD 40,000,000.00 MATURING: 01-Aug-2029 ISIN: XS2871018052 PLEASE BE ADVISED THAT THE INTEREST RATE FOR THE PERIOD 01-May-2026 TO 03-Aug-2026 HAS BEEN FIXED AT 4.88 PCT DAY BASIS: ACTUAL/360 INTEREST PAYABLE VALUE 03-Aug-2026 WILL AMOUNT TO: USD 12.73 PER USD 1,000.00 DENOMINATION ...
-
SpineGuard and Omnia Medical Obtain a New U.S. Patent for Their Innovative Application of DSG Technology to Sacroiliac Joint Fusion
PARIS & BOULDER, Colo.--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 - ALSGD), an innovative company specializing in Dynamic Surgical Guidance (DSG®) technology to enhance the safety and efficiency of bone implant placement, and Omnia Medical, an orthopedic implant company focused on innovative spine and sacroiliac solutions, today announced that their U.S. patent application has received notice of allowance from the USPTO (United States Patent and Trademark Office) for their inno...
-
Avia CEO & Founder Vickie Chen to Present at ChinaJoy 2026 on the Future of Skill-Based Casual Gaming
SAN FRANCISCO--(BUSINESS WIRE)--AviaGames, the leader in casual, skill-based gaming, today announced that CEO and Founder Vickie Chen will take the stage at ChinaJoy 2026 to present "Putting Players First, Uniting Brand & Performance: Redefining the North American Skill-Based Casual Gaming Sector." Drawing on nearly a decade of building one of North America's leading skill-based gaming companies, Vickie Chen will share practical insights into one of the industry's fastest-growing mobile gam...
-
Momentus Securities Advises City First Enterprises on Historic BBB+ Investment-Grade Rating
NEW YORK--(BUSINESS WIRE)--Momentus Securities, a mission-driven investment bank bridging the gap between mainstream capital and social impact, today announced its successful role as exclusive financial advisor to City First Enterprises (CFE) in achieving a BBB+ Issuer Default Rating from Fitch Ratings. With a balance sheet of $93 million, CFE’s rating demonstrates that capital markets access is no longer reserved for the largest CDFIs. This historic milestone refutes an industry-wide assumptio...
-
“We are breaking under the cuts”: Scarborough hospital workers call on Ford government to increase funding in the face of $36 million deficit
TORONTO--(BUSINESS WIRE)--2,500 frontline workers at the Scarborough Health Network (SHN), represented by CUPE, are facing heightened staffing issues while hospitals across the province cut jobs to account for growing deficits. The SHN is currently battling a $36 million budget shortfall. Chronic underfunding has resulted in a dual crisis of both reduced investment and capacity, at a moment when demand for hospital services only continues to grow. A survey of SHN workers conducted by CUPE in la...
-
ABL Diagnostics Announces Amendment to the Equity Line and Share Loan Agreement Between Its Main Shareholder ABL SA (Luxembourg) and Alumni Capital
WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Compartment B – ISIN: FR001400AHX6), a company specialized in vitro diagnostics, announces that on 23 July 2026 an Amended and Restated Equity Line and Share Loan Agreement was executed, amending the initial Equity Line and Share Loan Agreement dated 16 October 2025. The revised agreement has been entered into between the Company's controlling shareholder, Advanced Biological Laboratories (ABL) SA ("ABL Lux"), and Alumn...
-
Azelis: Transparency Notifications From UBS Group AG
ANTWERP, Belgium--(BUSINESS WIRE)--REGULATED INFORMATION In accordance with Article 14 of the Belgian Transparency law of 2 May 2007, Azelis Group NV (Brussels:AZE) announces that on 22 July 2026 and 23 July 2026, it has received two transparency notifications from UBS Group AG. 1. Summary of the notifications UBS Group AG reported in its notification dated 22 July 2026, that on 20 July 2026, following an acquisition of equivalent financial instruments, UBS Group AG (taking into account the hol...
-
ABL Diagnostics annonce la signature d'un avenant au contrat d'Equity Line et de prêt de titres entre son actionnaire principal ABL SA (Luxembourg) et Alumni Capital
WOIPPY, France--(BUSINESS WIRE)--Regulatory News: ABL Diagnostics (Euronext Compartiment B – ISIN : FR001400AHX6), société spécialisée dans le diagnostic in vitro, annonce la conclusion, le 23 juillet 2026, d'un avenant (Amended and Restated Equity Line and Share Loan Agreement) révisant le contrat initial d'Equity Line et de prêt de titres du 16 octobre 2025. Cet accord révisé a été conclu entre son actionnaire de contrôle, Advanced Biological Laboratories (ABL) SA (« ABL Lux »), et les fonds...
-
SpineGuard et Omnia Medical obtiennent un nouveau brevet américain pour leur application innovante de la technologie DSG à la fusion de l'articulation sacro-iliaque
PARIS & BOULDER, Colorado--(BUSINESS WIRE)--Regulatory News: SpineGuard (FR0011464452 - ALSGD), entreprise innovante qui déploie sa technologie digitale de guidage chirurgical (DSG®) par mesure locale de la conductivité électrique des tissus en temps réel pour sécuriser et simplifier le placement d’implants osseux, et Omnia Medical LLC, société américaine développant et commercialisant des solutions technologiques innovantes pour la chirurgie de la colonne vertébrale et du bassin, annoncent auj...
-
Grafana Labs Ships Six Tools That Power Agentic Operations From Planning to Production
NEW YORK--(BUSINESS WIRE)--Grafana Labs, the company behind the open observability cloud, today announced the general availability of six AI capabilities during its inaugural AI Week, extending Grafana Assistant into an agentic operations layer that detects, investigates, and remediates production issues at the pace AI now creates them. The releases include Grafana Assistant Investigations, Grafana Assistant Workspace, Grafana Assistant Automations, the Grafana Cloud MCP server, gcx, and Grafan...